The NIH NIAID DEA OA OFC ACQUISITIONS supports the National Institute of Allergy and Infectious Diseases in advancing research to prevent, diagnose, and treat infectious, immunologic, and allergic diseases. Its core mission centers on acquiring cutting-edge laboratory instrumentation, biotechnologic...
The NIH NIAID DEA OA OFC ACQUISITIONS supports the National Institute of Allergy and Infectious Diseases in advancing research to prevent, diagnose, and treat infectious, immunologic, and allergic diseases. Its core mission centers on acquiring cutting-edge laboratory instrumentation, biotechnological research services, and specialized analytical capabilities to enable breakthroughs in vaccine development, immune response characterization, and pathogen detection. Strategic priorities include expanding high-throughput immune epitope discovery, enhancing biosafety-compliant testing infrastructure, and sustaining advanced imaging and diagnostic platforms critical to public health preparedness. The agency actively funds research and development in biotechnology, particularly in T cell immunology and biological product innovation, often through SBIR and other small business innovation channels.
Procurement patterns reveal a strong emphasis on analytical laboratory instrumentation, maintenance of specialized scientific equipment such as confocal and ImageStream microscopes, and contract services for biological testing and validation. The agency frequently utilizes combined and long-term service contracts to ensure continuity of mission-critical instrumentation operation and data integrity. Research services in biotechnology and life sciences are procured through competitive solicitations, often aligned with NIH’s broader extramural research goals.
Industry preferences are concentrated in analytical laboratory instrument manufacturing, biological product development, and specialized testing laboratories. The agency demonstrates consistent support for small business set-asides, particularly through SBA programs, encouraging innovation from emerging life science vendors. Vendor relationships are built around technical expertise in immunology tools, biosafety-compliant maintenance, and validated research services, favoring firms with deep domain knowledge in infectious disease diagnostics and bioresearch infrastructure.
Organized under the National Institutes of Health within the Department of Health and Human Services, this office operates as a specialized acquisition unit supporting NIAID’s scientific mission. It leverages federal procurement vehicles including SBIR, GSA schedules, and direct award contracts to secure mission-critical capabilities. Its geographic footprint is centralized within NIH’s Bethesda campus, serving as a hub for high-containment and precision research operations.
